Depression Side Effect Labeling Awareness Act of 2019

United States116th CongressHR-4404House of Representatives
Updated: Sep 20, 2019

Summary

Depression Side Effect Labeling Awareness Act of 2019 This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.